Prophylaxis of ifosfamide toxicity with oral acetylcysteine.
D000111:Acetylcysteine / Q000627:therapeutic use*; D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003520:Cyclophosphamide / Q000031:analogs & derivatives*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006417:Hematuria / Q000139:chemically induced* / Q000517:prevention & control; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced
D003520:Cyclophosphamide; D007069:Ifosfamide; D000111:Acetylcysteine